Eevia Health Plc receives a 750 KSEK / 63 KEUR sales order for a bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received a first sales order from a new customer in Indonesia of c. 63 KEUR for Feno-Myrtillus® 36 Organic, an organically certified bilberry extract.

The Indonesian customer is new to Eevia. The customer is a procurement company for their sister company. The sister company is a large ophthalmic pharmaceutical company in Indonesia. Since 2018 the company has operated a state-of-the-art factory for human health supplements and cosmetics. Branded consumer products are marketed only in Indonesia through the company´s own sales channels.

The sales value to Eevia of this new order is c. KEUR 63 EUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic, which is an organically certified bilberry extract purified and standardized with 36% anthocyanins.

The start order is expected to be followed by further repeat orders in the future.

“We are thrilled to get a new high-end customer in Southeast Asia. Indonesia is a large country with 280 million citizens and this customer has a very robust quality focus and a distinct brand.” says Anna-Maija Vanhatalo, Customer Relations Manager with responsibility for Southeast Asia.

 

 

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]                      

Telephone: +358 400 22 5967                         

 

 

 

 

 

 

 

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth